We Now Have TWO Antivirals To Battle CoVid. Xocova, or ensitrelvir, was FDA-approved in May 2026 specifically for post-exposure prevention of symptomatic COVID-19 in adults and children 12 and over. #COVID19 #Xocova #Ensitrelvir #Paxlovid #Antiviral
We Now Have TWO Antivirals To Battle CoVid. Xocova, or ensitrelvir, was FDA-approved in May 2026 specifically for post-exposure prevention of symptomatic COVID-19 in adults and children 12 and over. #COVID19 #Xocova #Ensitrelvir #Paxlovid #Antiviral
0 views
Published on 22/08/2026 19:21
We Now Have TWO Antivirals To Battle CoVid. Xocova, or ensitrelvir, was FDA-approved in May 2026 specifically for post-exposure prevention of symptomatic COVID-19 in adults and children 12 and over. #COVID19 #Xocova #Ensitrelvir #Paxlovid #Antiviral
0 comments
?